+ 4.55
+ 1.46%
+ 1.24
+ 0.4%
+ 2.97
+ 0.79%
+ 0.49
+ 0.32%
+ 1.37
+ 0.8%

Resolve Digital Health's Medical Cannabis Vaporizer Approved By Health Canada

March 26, 2019 3:26 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Resolve Digital Health's Medical Cannabis Vaporizer Approved By Health Canada

Medical cannabis consumers in Canada might soon have a new paraphernalia option. 

Resolve Digital said Tuesday the first product in its range of smart vaporizers, the Resolve MD, received the approval for a medical device license for cannabis use from Health Canada

The Cannabis Capital Conference returns to Toronto April 17-18!

What Happened

Resolve Digital said it managed to satisfy the strict regulatory standards in place for medical device establishment licenses. The license allows Resolve to distribute its vaporizer for medical purposes and is issued separately from a medical device license. 

Why It's Important

The vaporizer received the first cannabis-related medical device license issued under Canada's new regulatory system, Resolve said.

Large cannabis producers like Canopy Growth Corp (NYSE:CGC) also provide medical vaporizers that were previously approved. For example, Canopy's Volcano Medic vaporizer was licensed back in 2014. 

The Resolve MD is a smart vaporizer that uses technology that ensures consistent dosing using pre-fill proprietary pods with pre-selected cannabis formulations.

The company's receipt of a medical device license means the vaporizer is fully compliant with Health Canada's regulations for such devices, including satisfying medical device, biological and electrical standards throughout the design and manufacturing process. 

What's Next

Resolve has plans to further expand its market into other countries and is seeking similar certifications as the one announced Tuesday in other regions — particularly Europe, which is poised to become the largest medical cannabis market within five years. 

Aside from vaporizers, Resolve said it is also working on an app that would help patients capture data on medical conditions, prescriptions, family history, lifestyle and effectiveness per dose, in order to improve their medical cannabis treatment experience.

Related Links:

Cronos Group Reports 250% Revenue Growth In Q4

Canopy Growth Receives License For New Brunswick Facility From Health Canada


Cannabis Markets

Related Articles

Arkansas Medical Weed Sales Reach $175M In 2020, Projected To Double In 2021

Arkansas welcomed medical marijuana sales back in May 2019, only to see substantial market growth last year, with sales hitting the $175 million mark, reports Marijuana Business Daily. There was a record $1.22 million day, per Marijuana Business Factbook estimates. read more

Cannabis Movers & Shakers: Vireo Health, Flora, MJardin, Arcview, Viridian Capital Advisors

Here is a summary of the latest leadership changes within the cannabis industry. read more

Juva Life Obtains California Cultivation License For Stockton Facility

Life sciences company Juva Life Inc. (CSE: JUVA) (OTCQX: JUVAF) has obtained a state-approved cannabis cultivation license for its 30,000 square-foot facility in Stockton, California. read more

Alcanna Spins-Out Cannabis Business, Combines With YSS To Form Nova Cannabis

Alcohol and cannabis retailer Alcanna Inc. (TSX: CLIQ) (OTC: LQSIF) has agreed to spin-out its retail cannabis business into a separate company and merge it with YSS Corp. (TSX-V: YSS) (WCN: A2PMAX) (OTC: YSSCF). read more

The Future Of Vaping: It's Going To Get Even Better

This article by Tammy Taylor was originally published on Cannabis & Tech Today, and appears here with permission. It all started with the nic-a-like (first generation), then clearomizer (second generation), and mod (third generation). The pod, currently the fourth generation, is quickly gaining popularity. read more